Public Notifications

(JULY 24, 2016 – LIMITS AND CONDITIONS REMOVED)

The Inquiry Committee, pursuant to Section 36 of the Health Professions Act, has reached an agreement with the pharmacist registrant whereby the registrant consented to undertakings involving regular monitoring for fitness to practice pharmacy. The undertakings include, but are not limited to:

1. Routine and random medical monitoring;

2. Informing all managers and employers with whom he gains employment of his medical condition and the need to maintain vigilance with respect to recovery and the possibility of relapse, and the limits and conditions on his registration pursuant to the agreement;

3. Ensuring that all managers and employers with whom he gains employment submits a written statement to the College declaring their awareness of his medical condition and the agreement;

4. Not being involved in the dispensing, ordering, contact, destruction, counting or otherwise handling of opiate medications and other medications with abusive potential, including benzodiazepines, stimulants and sedative medications such as Zopiclone;

5. Being restricted from the following roles in his practice:

   1. an owner or manager of a pharmacy;
   2. a director of a corporation that owns a pharmacy; and
   3. a preceptor.

    

6. Notifying the College of:

   1. all changes in his places of employment as a pharmacist
   2. all changes in residential address and phone number; and
   3. all changes in medical provider.

    

The agreement will remain in place for a minimum of two years of continuous pharmacy practice. The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition. The Inquiry Committee is satisfied that the undertakings will protect the public.